Keros Therapeutics, Inc. (KROS)
11.02
-0.21
(-1.87%)
USD |
NASDAQ |
Sep 03, 15:44
Keros Therapeutics Net Income (Annual) : 87.01M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 87.01M |
| December 31, 2024 | -187.35M |
| December 31, 2023 | -152.99M |
| December 31, 2022 | -104.68M |
| Date | Value |
|---|---|
| December 31, 2021 | -58.74M |
| December 31, 2020 | -45.36M |
| December 31, 2019 | -12.34M |
| December 31, 2018 | -1.335M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Incyte Corp. | 1.287B |
| Nurix Therapeutics, Inc. | -264.46M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| Anika Therapeutics, Inc. | -9.979M |